Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Felix Baker

Affiliations

  • Large Shareholder, Director at Neoleukin Therapeutics Inc. (NLTX), 2019-10-15
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
  • Large Shareholder, Director at Incyte Corp (INCY), 2019-10-02
  • Large Shareholder, Director at Igm Biosciences Inc. (IGMS), 2019-09-20
  • Large Shareholder, Director at Acadia Pharmaceuticals Inc (ACAD), 2019-09-20
  • Large Shareholder, Director at Kodiak Sciences Inc. (KOD), 2019-09-20
  • Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
  • Large Shareholder at Atreca Inc. (BCEL), 2019-06-26
  • Large Shareholder, Director at Seattle Genetics Inc (SGEN), 2019-06-07
  • Large Shareholder, Director at Kiniksa Pharmaceuticals Ltd. (KNSA), 2019-06-07
  • Large Shareholder, Director at Beigene Ltd. (BGNE), 2019-06-07
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2019-05-30
  • Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Large Shareholder at Invitae Corp (NVTA), 2018-03-29
  • Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2018-01-19
  • Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
  • Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
  • Other at Xoma Corp (XOMA), 2015-07-23
  • Other at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
  • Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
  • Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
  • Large Shareholder at Diadexus Inc. (DDXS), 2012-02-01
  • Large Shareholder at Adolor Corp (ADLR), 2012-01-03
  • Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
  • Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
  • Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SGEN $59.46 294,178 Large Shareholder, Director 40,885,092 2016-11-08 Filing
SGEN $59.46 32,122 Large Shareholder, Director 4,874,864 2016-11-08 Filing
SGEN $58.74 50,667 Large Shareholder, Director 40,590,914 2016-11-07 Filing
SGEN $58.74 5,533 Large Shareholder, Director 4,842,742 2016-11-07 Filing
SGEN $55.99 18,616 Large Shareholder, Director 40,540,247 2016-11-03 Filing